Integrated Suicide & Trauma Therapy for Suicide Risk
Condition(s) studied
Investigational drug(s) / intervention(s)
Integrated Suicide and Trauma Therapy: 12-week trauma therapy for suicide risk
Study summary
The investigators have developed a novel suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate the specific impacts of childhood trauma on suicide risk. The aim of this pilot is to test 12-weeks of ISTT to alleviate suicide risk among individuals with a history of childhood trauma and current suicidality.
Eligibility
Primary outcome measure(s)
- Change in Beck Scale for Suicide Ideation (BSS) score — From baseline to 1 week post-therapy
Beck Scale for Suicide Ideation is a 21-item self-report scale that quantifies suicidal ideation. Items are scored 0 to 2 and yield a total score ranging from 0 to 38. Higher scores reflect greater severity of suicidal ideation. - Feasibility and acceptability of ISTT — From baseline to 1 week post-therapy
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), Feasibility of Intervention Measure (FIM), in addition to a feedback survey and interview created in-house with questions designed to collect quantitative and qualitative feedback from participants with respect to the feasibility and acceptability of the BSTT intervention.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| St. Michael's Hospital | Toronto | Ontario | Recruiting |
More Unity Health Toronto trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05613972 on ClinicalTrials.gov ↗ ← All trials in Canada